“DIA 2016 52nd Annual Meeting is the largest global interdisciplinary event that brings together 7,000+ key thought leaders and innovators from industry, academia, regulatory and government agencies, health, patient, and philanthropic organizations from around the globe – and across all disciplines involved in the discovery, development, and life cycle management of health care products.”

Heads of our Americas, EMEA and APAC offices, Ian Montague and Shehnaz Vakharia, will be representing ADAMAS at this year’s DIA Conference.  With a large staff of global full-time consultants, Ian and Shehnaz are ready to discuss all of your local and worldwide QA needs including Investigator Site Audits, Vendor Systems Audits, Pharmacovigilance, Laboratory and Manufacturing audits, as well as specialized services for Mock Inspections, Inspection Readiness and GxP training. As a recognized QA thought leader, we look forward to sharing our views on the latest QA trending topics that are transforming the industry such as:

  • The Language of Consent – Will the use of electronic media to provide IC information to subjects be as practical and understandable as it’s required to be?
  • Conducting Remote Vendor Audits – Will it work for you?
  • Investigator Oversight – Five Chronic Audit Observations

So stop by our Booth #743, meet our team, share insights, and  enter our prize draw to win an amazing Amazon Echo.

If you’re not attending but would like to learn more about ADAMAS’s services, give us a call at +1-919-341-3361 or contact Steve Bliss atsteve.bliss@adamasconsulting.com.

Come and meet us there!

The ADAMAS Corporate Brochure 2016


Brochure – Please download the ADAMAS brochure describing our QA services and contact details.

Regulatory Environment


The development of medicines is the most regulated industry in the world, and compliance at each stage of the research and development process, as well as after licensing, is critical to ensuring high quality and safe medicines reach patients in a timely manner.



ADAMAS’s consultants have expertise across the G’X’Ps in pre-clinical, clinical and post-licensing areas. They have worked across many different therapeutic areas and product types including oncology, vaccines, biologics, medical devices and gene therapy. As a company we have developed close partnerships with our clients to support them in their development programmes and post-licensing activities, and to guide them successfully through their worldwide regulatory inspections.


How to be a Clinical Auditor


‘So you want to be a Clinical Auditor?’, an article written by CEO Dr. Patricia Fitzgerald.

Benchmarking Data


Please download our benchmarking data sheet, to see how these data compare with your own performance. To discuss a more detailed report, or analysis of a data subset, please get in touch.

Is your QMS compliant?


Is your QMS compliant to the upcoming ICH E6 Addendum? Download our 5-point checklist

ICH (E6) R2 Addendum - Step 4


Please enter your details to complete the download.



Want to become one of the first businesses to access our exclusive data?
Get going and start reducing risk today. Pre register now.